Oppenheimer Asset Management Inc. Purchases 3,347 Shares of Varex Imaging (VREX)
Oppenheimer Asset Management Inc. grew its position in shares of Varex Imaging (NASDAQ:VREX) by 82.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,384 shares of the company’s stock after purchasing an additional 3,347 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Varex Imaging were worth $250,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in VREX. Keeley Teton Advisors LLC bought a new position in Varex Imaging during the 3rd quarter worth approximately $3,811,000. Royce & Associates LP lifted its holdings in Varex Imaging by 39.4% in the 3rd quarter. Royce & Associates LP now owns 190,360 shares of the company’s stock worth $6,442,000 after buying an additional 53,805 shares during the period. Allianz Asset Management GmbH purchased a new stake in Varex Imaging in the 3rd quarter worth approximately $2,644,000. Dimensional Fund Advisors LP lifted its holdings in Varex Imaging by 92.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 514,898 shares of the company’s stock worth $17,424,000 after buying an additional 247,229 shares during the period. Finally, Schwab Charles Investment Management Inc. lifted its holdings in Varex Imaging by 40.2% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 221,934 shares of the company’s stock worth $7,511,000 after buying an additional 63,680 shares during the period. Hedge funds and other institutional investors own 92.79% of the company’s stock.
Several equities research analysts have weighed in on the company. J P Morgan Chase & Co cut Varex Imaging from a “neutral” rating to an “underweight” rating and set a $33.00 price objective for the company. in a report on Wednesday, October 4th. Zacks Investment Research upgraded Varex Imaging from a “strong sell” rating to a “hold” rating in a report on Thursday, October 5th. Finally, Jefferies Group increased their price objective on Varex Imaging to $39.00 and gave the stock a “buy” rating in a report on Friday, November 10th.
Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Thursday, November 9th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.07. The business had revenue of $216.00 million during the quarter, compared to analysts’ expectations of $213.73 million. The company’s quarterly revenue was up 25.5% on a year-over-year basis. equities analysts predict that Varex Imaging will post 1.82 EPS for the current fiscal year.
In other news, insider Sunny Sanyal sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $36.50, for a total value of $1,825,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/oppenheimer-asset-management-inc-purchases-3347-shares-of-varex-imaging-vrex/1772398.html.
About Varex Imaging
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.